Clinical features and outcomes of calciphylaxis in Chinese patients with chronic kidney disease.
- Published in:
- Nephrology, 2023, v. 28, n. 6, p. 305, doi. 10.1111/nep.14156
- By:
- Publication type:
- Article
Works matching IS 13205358 AND DT 2023 AND VI 28 AND IP 6
Results: 6
1
2
Waldenström macroglobulinaemia-associated pseudohypercreatininaemia.
- Published in:
- Nephrology, 2023, v. 28, n. 6, p. 356, doi. 10.1111/nep.14157
- By:
- Publication type:
- Article
3
Urinary liver-type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone.
- Published in:
- Nephrology, 2023, v. 28, n. 6, p. 345, doi. 10.1111/nep.14162
- By:
- Publication type:
- Article
4
Risk factor for progression to kidney failure with replacement therapy in elderly patients with chronic kidney disease: A retrospective single-centre cohort study.
- Published in:
- Nephrology, 2023, v. 28, n. 6, p. 336, doi. 10.1111/nep.14163
- By:
- Publication type:
- Article
5
Baicalin and baicalein attenuate hyperuricemic nephropathy via inhibiting PI3K/AKT/NF-κB signalling pathway.
- Published in:
- Nephrology, 2023, v. 28, n. 6, p. 315, doi. 10.1111/nep.14159
- By:
- Publication type:
- Article
6
The kidney failure risk equation predicts kidney failure: Validation in an Australian cohort.
- Published in:
- Nephrology, 2023, v. 28, n. 6, p. 328, doi. 10.1111/nep.14160
- By:
- Publication type:
- Article